Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma

DOI: 10.2147/OTT.S173275

Keywords: hepatocellular carcinoma, sorafenib, monocyte-to-lymphocyte ratio, prognosis

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text